Cargando…
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
PURPOSE: The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past 7 days, but there are contexts where a 24-hour recall may be desirable. The purpose of this analysis was to investigate the reliability and val...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241696/ https://www.ncbi.nlm.nih.gov/pubmed/36897529 http://dx.doi.org/10.1007/s11136-023-03374-5 |
_version_ | 1785054044302082048 |
---|---|
author | Lee, M. K. Basch, E. Mitchell, S. A. Minasian, L. M. Langlais, B. T. Thanarajasingam, G. Ginos, B. F. Rogak, L. J. Mendoza, T. R. Bennett, A. V. Schrag, D. Mazza, G. L. Dueck, A. C. |
author_facet | Lee, M. K. Basch, E. Mitchell, S. A. Minasian, L. M. Langlais, B. T. Thanarajasingam, G. Ginos, B. F. Rogak, L. J. Mendoza, T. R. Bennett, A. V. Schrag, D. Mazza, G. L. Dueck, A. C. |
author_sort | Lee, M. K. |
collection | PubMed |
description | PURPOSE: The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past 7 days, but there are contexts where a 24-hour recall may be desirable. The purpose of this analysis was to investigate the reliability and validity of a subset of PRO-CTCAE items captured using a 24-hour recall. METHODS: 27 PRO-CTCAE items representing 14 symptomatic adverse events (AEs) were collected using both a 24-hour recall (24 h) and the standard 7 day recall (7d) in a sample of patients receiving active cancer treatment (n = 113). Using data captured with a PRO-CTCAE-24h on days 6 and 7, and 20 and 21, we computed intra-class correlation coefficients (ICC); an ICC ≥ 0.70 was interpreted as demonstrating high test–retest reliability. Correlations between PRO-CTCAE-24h items on day 7 and conceptually relevant EORTC QLQ-C30 domains were examined. In responsiveness analysis, patients were deemed changed if they had a one-point or greater change in the corresponding PRO-CTCAE-7d item (from week 0 to week 1). RESULTS: PRO-CTCAE-24h captured on two consecutive days demonstrated that 21 of 27 items (78%) had ICCs ≥ 0.70 (day 6/7 median ICC 0.76), (day 20/21 median ICC 0.84). Median correlation between attributes within a common AE was 0.75, and the median correlation between conceptually relevant EORTC QLQ-C30 domains and PRO-CTCAE-24 h items captured on day 7 was 0.44. In the analysis of responsiveness to change, the median standardized response mean (SRM) for patients with improvement was − 0.52 and that for patients with worsening was 0.71. CONCLUSION: A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-023-03374-5. |
format | Online Article Text |
id | pubmed-10241696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102416962023-06-07 Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period Lee, M. K. Basch, E. Mitchell, S. A. Minasian, L. M. Langlais, B. T. Thanarajasingam, G. Ginos, B. F. Rogak, L. J. Mendoza, T. R. Bennett, A. V. Schrag, D. Mazza, G. L. Dueck, A. C. Qual Life Res Article PURPOSE: The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past 7 days, but there are contexts where a 24-hour recall may be desirable. The purpose of this analysis was to investigate the reliability and validity of a subset of PRO-CTCAE items captured using a 24-hour recall. METHODS: 27 PRO-CTCAE items representing 14 symptomatic adverse events (AEs) were collected using both a 24-hour recall (24 h) and the standard 7 day recall (7d) in a sample of patients receiving active cancer treatment (n = 113). Using data captured with a PRO-CTCAE-24h on days 6 and 7, and 20 and 21, we computed intra-class correlation coefficients (ICC); an ICC ≥ 0.70 was interpreted as demonstrating high test–retest reliability. Correlations between PRO-CTCAE-24h items on day 7 and conceptually relevant EORTC QLQ-C30 domains were examined. In responsiveness analysis, patients were deemed changed if they had a one-point or greater change in the corresponding PRO-CTCAE-7d item (from week 0 to week 1). RESULTS: PRO-CTCAE-24h captured on two consecutive days demonstrated that 21 of 27 items (78%) had ICCs ≥ 0.70 (day 6/7 median ICC 0.76), (day 20/21 median ICC 0.84). Median correlation between attributes within a common AE was 0.75, and the median correlation between conceptually relevant EORTC QLQ-C30 domains and PRO-CTCAE-24 h items captured on day 7 was 0.44. In the analysis of responsiveness to change, the median standardized response mean (SRM) for patients with improvement was − 0.52 and that for patients with worsening was 0.71. CONCLUSION: A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-023-03374-5. Springer International Publishing 2023-03-10 2023 /pmc/articles/PMC10241696/ /pubmed/36897529 http://dx.doi.org/10.1007/s11136-023-03374-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lee, M. K. Basch, E. Mitchell, S. A. Minasian, L. M. Langlais, B. T. Thanarajasingam, G. Ginos, B. F. Rogak, L. J. Mendoza, T. R. Bennett, A. V. Schrag, D. Mazza, G. L. Dueck, A. C. Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title | Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title_full | Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title_fullStr | Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title_full_unstemmed | Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title_short | Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period |
title_sort | reliability and validity of pro-ctcae® daily reporting with a 24-hour recall period |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241696/ https://www.ncbi.nlm.nih.gov/pubmed/36897529 http://dx.doi.org/10.1007/s11136-023-03374-5 |
work_keys_str_mv | AT leemk reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT basche reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT mitchellsa reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT minasianlm reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT langlaisbt reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT thanarajasingamg reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT ginosbf reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT rogaklj reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT mendozatr reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT bennettav reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT schragd reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT mazzagl reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod AT dueckac reliabilityandvalidityofproctcaedailyreportingwitha24hourrecallperiod |